Cue Biopharma (CUE) — Financial Flexibility Index
Cue Biopharma (CUE) has a Financial Flexibility Index of -0.49x as of September 2025. Free cash flow of $-9.02 Million (operating CF $-9.02 Million minus capex $0.00) represents 0% of total liabilities ($18.40 Million). Also explore CUE net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cue Biopharma Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Cue Biopharma across 10 annual periods. Check asset allocation strategy of Cue Biopharma to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Cue Biopharma (2015–2024)
Year-by-year free cash flow to debt coverage for Cue Biopharma. For the full company profile including market capitalisation, see Cue Biopharma (CUE) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.47x | $-36.26 Million | $-36.33 Million | $14.69 Million | ▼ -51.0% |
| 2023 | -1.63x | $-39.96 Million | $-39.96 Million | $24.45 Million | ▼ -0.5% |
| 2022 | -1.63x | $-41.63 Million | $-41.81 Million | $25.60 Million | ▲ +23.2% |
| 2021 | -2.12x | $-37.92 Million | $-38.84 Million | $17.91 Million | ▼ -36.9% |
| 2020 | -1.55x | $-31.90 Million | $-32.49 Million | $20.62 Million | ▲ +14.4% |
| 2019 | -1.81x | $-30.75 Million | $-30.80 Million | $17.02 Million | ▲ +16.2% |
| 2018 | -2.16x | $-24.56 Million | $-26.41 Million | $11.39 Million | ▼ -4.9% |
| 2017 | -2.05x | $-10.99 Million | $-12.19 Million | $5.35 Million | ▲ +58.4% |
| 2016 | -4.94x | $-5.45 Million | $-5.97 Million | $1.10 Million | ▼ -105.7% |
| 2015 | -2.40x | $-903.28K | $-1.66 Million | $376.30K | — |